Molecular pathology of hemangiopericytomas accompanied by severe hypoglycemia: Oncogenes, tumor-suppressor genes and the insulin-like growth factor family

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 6, 1998, Pages 307-314

  Pavelic K ^a   Cabrijan T ^b   Hrascan R ^a   Vrkljan, M ^b   Lipovac, M ^b   Kapitanovic S ^a   Gall Troselj K ^a   Herak Bosnar, M ^a   Tomac, A ^b   Grskovic B ^a   Karapandza N ^b   Pavelic L J ^c   Kruslin B ^b   Spaventi, S ^d   Pavelic J ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c KBC Zagreb   (Croatia)

^d CROATIAN ACADEMY OF SCIENCES AND ARTS   (Croatia)

Author keywords

Genes; GF II; Hemangiopericytoma; Hypoglycemia; IGF I; IGF IR; Oncogenes; Tumor suppressor

Indexed keywords

MYC PROTEIN; PROTEIN P53; RAS PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CELL MEMBRANE; GENE ACTIVATION; GENE EXPRESSION; HEMANGIOPERICYTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; ONCOGENE; ONCOGENE C JUN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TUMOR SUPPRESSOR GENE;

ABDOMINAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HEMANGIOPERICYTOMA; HUMANS; HYPOGLYCEMIA; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; ONCOGENES; PERITONEAL NEOPLASMS; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SOMATOMEDINS;

EID: 15444359186     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050174     Document Type: Article

References (33)

1. Arteaga CL (1992) Interference of the IGF system as a strategy to inhibit breast cancer growth. Breast Cancer Res Treat 22:101-106
2. Baserga R (1995) The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55:249-252
3. Bothwell M (1983) Insulin and somatomedin MSA promote nerve growth factor-independent neurite formation by cultured chick dorsal root ganglionic sensory neurons. Prog Clin Biol Res 118:225-231
4. Crews CM, Erikson RL (1993) Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74:215-217
5. Daughaday WH, Kapadia M (1989) Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA 86:6778-6782
6. Dechiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin like growth factor II gene disrupted by targeting. Nature 345:78-80
7. De Leon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG (1988) Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152:398-405
8. Dickson RB, Thompson EW, Lippman ME (1990) Regulation of proliferation, invasion, and growth factor synthesis in breast cancer by steroids. J Steroid Biochem Mol Biol 37:305-316
9. Enzinger FM, Weiss SW (1996) Soft tissue tumors. Mosby, St. Louis, pp 713-733
10. Gall-Trošelj K, Kušić B, Pećina-Šlaus N, Pavelić K, Pavelić J (1995) Nested polymerase chain reaction for detection of hepatitis C virus RNA in blood derivatives. Eur J Clin Chem Clin Biochem 33:733-736
11. Giuliano M, Vento R, Lauricella M, Calvaruso G, Carabillo M, Tesoriere G (1996) Role of insulin like growth factors in autocrine growth of human retinoblastoma Y79 cells. Eur J Biochem 236:523-532
12. Hrašćan R, Pavelić K, Pavičić D, Križanac Š, Štajeer-Štitić V, Pečur L, Spaventi Š, Klimpfinger M, Pavelić J (1996) Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor. Anticancer Res 16:3761-3766
13. Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer 65:311-320
14. Moses AC, Nissley SP, Short PA, Rechler MM, Podskalny JM (1980) Purification and characterization of multiplication-stimulating activity. Eur J Biochem 103:387-400
15. Myers MG, Sun XJ, Cheatham B, Jachna BR, Glasheen EM, Backer JM, White MF (1993) IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132:1421-1430
16. Oelz O, Jakob A, Froesch ER (1970) Nonsuppressible insulin-like activity (NSILA) of human serum. Eur J Clin Invest 1:48-53
17. Pavelić J, Gull-Trošelj K, Hlavka V, Pavelić ZP, Gluckman J, Stambrook PJ, Pavelić K (1994) nm23-H1 protein in oligodendrogliomas. Int J Oncol 4:1399-1403
18. Pavelić K, Vrbanec D, Marušić S, Levanat S, Čabrijan T (1986) Autocrine tumour growth regulation by somatomedin C: an in-vitro model. J Endocrinol 109:233-238
19. Pavelić K, Despot N, Levanat S, Časl MT (1990a) Protective role of transforming growth factor β (TGE β) in tumor-induced degradation of basement membranes. Biol Chem Hoppe-Seyler 371:687-692
20. Pavelić K, Pavelić ZP, Denton D, Reising J, Khalily M, Preisler HD (1990b) Immunohistochemical detection of C-MYC oncoprotein in paraffin embedded tissues. J Exp Pathol 5:143-153
21. Pavelić K, Pavelić ZP, Preisler HD (1991) C-MYC detection in bone marrow biopsies. Leukemia Res 15:1075-1078
22. Peyrat JP, Bonneterre J, Djilane J, Dusanter-Fourt I, Barenton B, Beuscart R, Leroy-Martin B, Demaille A (1988) Insulin-like growth factor I receptor (IGF 1-R) in human breast cancer: relation with estradiol and progesterone receptors (ER, PgR). In: Bresciani F, King RJB, Lippman ME, Raynaud JP (eds), Hormones and cancer. vol 3. Raven, New York, pp 223-226
23. Pierson RW, Temin HM (1972) The partial purification from calf serum of a fraction with multiplication stimulating activity for chicken fibroblasts in cell culture and with non-suppressible insulin-like activity. J Cell Physiol 79:319-330
24. Poon B, Dixon D, Ellis E, Roth RA, Rutter WJ, Wang L-H (1991) Molecular basis of the activation of the tumorigenic potential of Gag-insulin receptor chimeras. Proc Natl Acad Sci USA 88:877-881
25. Salmon WD, Daughaday WH (1957) A Hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825-836
26. Sambrook J, Fritsch RF, Maniatis T (1989) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor
27. Schonenle E, Zapf J, Hauri C, Steiner T, Froesch ER (1985) Comparison of an in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol 108:167-174
28. Stiles CD, Sosenko IRS, D'Ercole AJ, Smith BT (1985) Relation of kidney tissue somatomedin-C insulin-like growth factor I to postnephrectomy renal growth in the rat. Endocrinology 1:2397-2401
29. Štorga D, Pećina-Šlaus N, Pavelić ZP, Pavelić K (1992) c-fms is present in primary tumours as well as in their metastases in bone marrow. Int J Exp Pathol 73:527-533
30. Sugarman BJ, Aggarwall BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM (1985) Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943-945
31. Van Buull-Offers S, Van Den Brande JE (1982) Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity. Acta Endocrinol 99:150-160
32. White MF, Kahn CR (1994) The insulin signaling system. J Biol Chem 269:1-4
33. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N (1989) Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509-517